<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="145266">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01209559</url>
  </required_header>
  <id_info>
    <org_study_id>CDHA-RS/2011-156</org_study_id>
    <nct_id>NCT01209559</nct_id>
  </id_info>
  <brief_title>A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <brief_summary>
    <textblock>
      The objective of this study is to determine if the glottic view obtained with the air-Q
      Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA)
      is better than that obtained with the traditionally used intubating laryngeal mask airway
      (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare
      effectiveness of ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Study never initiated.
  </why_stopped>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Airway Management</condition>
  <arm_group>
    <arm_group_label>air-Q Intubating Laryngeal Airway</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA FastrachTM or ILMA</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy ASA class I and II patients scheduled for elective surgery under general
        anesthesia requiring the use of the LMA.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy ASA class I and II patients scheduled for elective surgery under general
             anesthesia requiring the use of the LMA

        Exclusion Criteria:

          -  history of acid reflux,

          -  a BMI ≥ 40kg.m-2,

          -  require endotracheal intubation,

          -  have predictors of difficult intubation,

          -  not candidates for insertion of an ILMA or LMA, including a mouth opening of less
             than 2.5 cm,

          -  cannot consent to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 30, 2017</lastchanged_date>
  <firstreceived_date>September 23, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Orlando Hung</investigator_full_name>
    <investigator_title>MD FRCPC</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
